Mercury Laboratories Limited (BSE: 538964)
Health Care · Pharmaceuticals · IN
Rs762.40
-0.25% today · -9.6% 1Y
Mercury Laboratories Limited (BSE: 538964) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $9.56M.
Over the last twelve months the share price has lost 9.6%, trading between 620.55 and 942.90.
Tweenvest scores Mercury Laboratories Limited across four factors: quality 78/100, value 43/100, growth 7/100, dividend 41/100. Its strongest factor is quality.
538964 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.56M
- Revenue (TTM)
- $7.80M
- P/E
- 21.97
- EPS
- 34.70
- Dividend yield
- 0.46%
- Beta (5Y)
- 0.40
- 52-week high
- Rs942.90
- 52-week low
- Rs620.55
- Avg volume (3M)
- —
- Shares outstanding
- 1.20M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,248.49 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $272.78 | -0.10% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $155.08 | +2.93% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.39 | +1.48% |
Figures last refreshed Aug 18, 2026.